{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T06:38:51Z","timestamp":1720679931046},"reference-count":20,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The General Practice Research Database (GPRD) has been used to identify associations between pregnancy medication exposures and birth defects, but experts have argued that databases such as this one cannot provide detailed information for the valid identification of complicated congenital anomalies. Our objective was to determine if the GPRD could be used to identify cases of neural tube defects (NTDs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>First, we created algorithms for anencephaly, encephalocele, meningocele, and spina bifida and used them to identify potential cases. We used the algorithms to identify 217 potential NTD cases in either a child's or a mother's record. We validated cases by querying general practitioners (GPs) <jats:italic>via<\/jats:italic> questionnaire. Where cases of NTD were identified in the mother's record, in addition to confirming the diagnosis, we asked the GPs if the diagnosis was for the mother or that of her fetus or offspring.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Two hundred seventeen cases were identified, and 165 GP questionnaires were returned. We validated an NTD diagnosis for 117 cases, giving our algorithms a positive predictive value (PPV) of 0.71. The PPVs varied by NTD type: 0.81 for anencephaly, 0.83 for cephalocele, 0.64 for meningocele, and 0.47 for spina bifida.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our identification algorithm was useful in identifying three of the four types of NTDs studied. Additional information is necessary to accurately identify cases of spina bifida. Copyright \u00a9 2008 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pds.1573","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T10:22:01Z","timestamp":1205749321000},"page":"434-444","source":"Crossref","is-referenced-by-count":16,"title":["Validation of neural tube defects in the full featured\u2014general practice research database"],"prefix":"10.1002","volume":"17","author":[{"given":"Scott","family":"Devine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne L.","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pat","family":"Tennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Thorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Olshan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_2","volume-title":"Stedman's Medical Dictionary","author":"Stedman TL","year":"2000"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2779(1998)4:4<247::AID-MRDD3>3.0.CO;2-P"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199911113412006"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.330.7491.574"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(84)90119-9"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(16)38924-4"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199103073241006"},{"issue":"4","key":"e_1_2_1_9_2","first-page":"43","article-title":"Pharmacogenetics and drug interactions: role in antiepileptic\u2010drug\u2010induced teratogenesis","volume":"42","author":"Lindhout D","year":"1992","journal-title":"Neurology"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/154.2.180"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1997.tb03065.x"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a010036"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.1.63"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb031395"},{"key":"e_1_2_1_15_2","volume-title":"Full Featured General Practice Research Database. The Premier Source of Healthcare Data From Primary Care. Facts and Figures","author":"MHRA","year":"2006"},{"key":"e_1_2_1_16_2","volume-title":"Full Featured General Practice Research Database. The Premeir Source of Healthcare Data From Primary Care. What is GPRD?","author":"MHRA","year":"2004"},{"key":"e_1_2_1_17_2","first-page":"36","volume-title":"GPRD Recording Guidelines for Vision Users","author":"MHRA","year":"2004"},{"issue":"2","key":"e_1_2_1_18_2","first-page":"S148","article-title":"The identification of pregnancies within the full featured\u2014General Practice Research Database","volume":"16","author":"Devine ST","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1269"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38300.665301.3A"},{"key":"e_1_2_1_21_2","first-page":"44","volume-title":"Clinical Guideline 6","year":"2003"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.1573","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.1573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T09:52:00Z","timestamp":1699955520000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.1573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,17]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.1002\/pds.1573"],"URL":"https:\/\/doi.org\/10.1002\/pds.1573","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,17]]}}}